Note: Ingredients listed on restricted chemical lists
EC/CAS
232-679-6/9005-25-8
Name of the chemical
Starch
Concentration
N/A
EC/CAS
232-674-9/9004-34-6
Name of the chemical
cellulose
Concentration
N/A
EC/CAS
231-545-4/7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
N/A
EC/CAS
25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
limit (SCL
EC/CAS
500-019-9/9004-64-2
Name of the chemical
hydroxypropylcellulose
Concentration
N/A
EC/CAS
202-307-7/9005-65-6
Name of the chemical
polyethyleneglycol sorbitan monooleate
Concentration
N/A
EC/CAS
202-785-7/94-13-3
Name of the chemical
Propylparaben; propyl 4-hydroxybenzoate
Concentration
N/A
EC/CAS
99-76-3
Name of the chemical
4-hydroxybenzoic acid, methyl ester
Concentration
N/A
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
N/A
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
General Information
Version
5
Revision date
2025-06-17
Product name
Gemfibrozil tablets, 450 and 600 mg
Product name
Gemfibrozil tablets, 450 and 600 mg
Identification on the label/Trade name
Lopid; Lopid UD; Gevilon; LIPUR; GD-Gemfibrozil
Chemical name
Mixture
1.2.1 Relevant identified uses
Pharmaceutical product for the treatment of high cholesterol (hyperlipidemia)
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H351, H361f, H401, H411
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
OSHA Classification of the substance or mixture
2.3 Other hazards
Not applicable (HNOC) An Occupational Exposure Value has been established for one or more of the ingredients (see Section 8).
Signal word
Warning
Hazard statements
H351 - Suspected of causing cancer H361f - Suspected of damaging fertility H411 - Toxic to aquatic life with long lasting effects
Precautionary statements
P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P280 - Wear protective gloves and protective clothing P273 - Avoid release to the environment P308 + P313 - IF exposed or concerned: Get medical advice/attention P391 - Collect spillage P405 - Store locked up P501 - Dispose of contents/container in accordance with local, regional, national, and international regulations as applicable
PBT Substances
& vPvB The product does not contain any substance(s) classified as PBT or vPvB. Endocrine Disruptor Information Chemical name This product does not contain any known or suspected endocrine disruptors.
2.1 Classification of the substance or mixture
GHS - Classification: Regulated according to Regulation (EC) 1272/2008 and/or other applicable regulations. Carcinogenicity Category 2 - (H351) Reproductive toxicity Category 2 - (H361f) Hazardous to the aquatic environment - acute Category 2 - (H401) Hazardous to the aquatic environment - chronic Category 2 - (H411) OSHA Classification Hazards not otherwise classified (HNOC) Not applicable Hazards classified under paragraph (d)(1)(ii) of 1910.1200 Not applicable
